[HLA B 27 uveitis in ankylosing spondylitis and reactive arthritis]

Area of Science:

• Ophthalmology and Rheumatology
• Immunogenetics

Context:

• Uveitis, particularly when associated with spondylarthropathies like ankylosing spondylitis and reactive arthritis, presents complex clinical challenges.
• The role of specific genetic markers in the pathogenesis and diagnosis of these conditions requires further elucidation.

Purpose:

• To investigate the clinical features of uveitis in patients with ankylosing spondylitis and reactive arthritis.
• To determine the frequency and significance of Human Leukocyte Antigen B27 (HLA-B27) positivity in this patient cohort.
• To explore the association between HLA-B27 and specific uveitis phenotypes (anterior, unilateral) and disease course (chronic, recurrent).

Summary:

• This study analyzed 64 uveitis patients, finding a 72% prevalence of HLA-B27 positivity.
• In HLA-B27 positive patients with ankylosing spondylitis and reactive arthritis, anterior uveitis occurred in 85% and unilateral affection in 92%.
• The study highlights HLA-B27 as a key genetic factor in spondylarthropathic uveitis, with chronic or recurrent disease observed in 17% and 11% of cases, respectively.

Impact:

• The findings underscore the importance of HLA-B27 testing for early diagnosis of ankylosing spondylitis in patients presenting with uveitis.
• This genetic marker can help predict disease phenotype and potentially guide management strategies for spondylarthropathic uveitis.
• Identifying HLA-B27 as a risk factor facilitates a more targeted approach to diagnosis and management, improving patient outcomes.